...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
AGORACOM NEWS FLASH

BREAKING: betterU closes deal with USA Paramount Staffing for their newly launched Ready-To-Go SaaS Enterprise skills development

  • Entered into an annual SaaS agreement with one of the largest staffing firms in the USA, Paramount Staffing
  • Paramount, is a $200+ Million USD Staffing Firm with over 300 employees across the USA and Canada
  • betterU has been able to curate and integrate a Ready-To-Go content library across top subjects so that HR managers could provide simple access to their entire organization

Betteru large

Hub On AGORACOM / Read Release / Watch Recent Interview

Due Dilligence

H1 2020 Potential Events

Posted by: BearDownAZ on Feb 25, 2020 12:19PM
URL: https://agoracom.com/ir/Resverlogix/foru...6-march-30-2020/messages/2259177#message

BETonMACE Cognitive Assessment Results Corporate Webcast Slides

Posted by: BearDownAZ on Dec 06, 2019 07:41PM
URL: https://www.resverlogix.com/upload/media...tonmace-cognitive-assessment-results.pdf

Post AHA Company Webcast Slides 11/18/19

Posted by: BearDownAZ on Nov 19, 2019 08:08AM
URL: https://www.resverlogix.com/upload/media...etonmace-post-aha-presentation-final.pdf
Resverlogix Corp. Links

NEJM BETonMACE Editorial - Epigenetic Therapeutics for Cardiovascular Disease Writing, Erasing, Reading, and Maybe Forgetting

Posted by: BearDownAZ on Mar 31, 2020 08:21AM
URL: https://jamanetwork.com/journals/jama/fullarticle/2763949

NEJM BETonMACE Publication - Effect of Apabetalone Added to Standard Therapy on Major Adverse Cardiovascular Events in Patients With Recent Acute Coronary Syndrome and Type 2 Diabetes A Randomized Clinical Trial

Posted by: BearDownAZ on Mar 31, 2020 08:20AM
URL: https://jamanetwork.com/journals/jama/fullarticle/2763951

The BET Protein Inhibitor Apabetalone Reduces Congestive Heart Failure Incidence in Patients with Acute Coronary Syndrome and Diabetes: Results from the BETonMACE Trial - ACC/WCC 2020 Poster

Posted by: BearDownAZ on Mar 31, 2020 08:18AM
URL: https://www.resverlogix.com/upload/media...682cf0/2020-03-16---chf-poster-final.pdf

Epigenetic Reader Inhibitor Apabetalone (RVX-208) Counters Proinflammatory Hyperactivation of CD14+ Monocytes from Patients with Type 2 Diabetes and Cardiovascular Disease - ACC/WCC 2020 Poster

Posted by: BearDownAZ on Mar 31, 2020 08:18AM
URL: https://www.resverlogix.com/upload/media.../acc2020-mela-moderated-poster-final.pdf

H1 2020 Potential Events

Posted by: BearDownAZ on Feb 25, 2020 12:19PM
URL: https://agoracom.com/ir/Resverlogix/foru...6-march-30-2020/messages/2259177#message

Epigenetics in CVD: A collection of PACE-CME symposium presentations

Posted by: BearDownAZ on Feb 11, 2020 10:52AM
URL: https://pace-cme.org/epigenetics-in-cvd/

Pharmacologic epigenetic modulators of alkaline phosphatase in chronic kidney disease

Posted by: BearDownAZ on Dec 10, 2019 09:16PM
URL: https://journals.lww.com/co-nephrolhyper...epigenetic_modulators_of_alkaline.3.aspx

Epigenetic Modulator Apabetalone Inhibits Monocyte Adhesion To Brain Endothelial Cells By Downregulating Key Neuroinflammation Markers In Vitro And In Vivo - CTAD 2019 Poster

Posted by: BearDownAZ on Dec 08, 2019 02:30PM
URL: https://www.resverlogix.com/upload/media...966f7d5/ctad-poster-final-2019-12-07.pdf

Post CTAD Webcast Transcript 12/6/19 via Imtesty

Posted by: BearDownAZ on Dec 08, 2019 02:21PM
URL: https://agoracom.com/ir/Resverlogix/foru...anscript-191206/messages/2251871#message

BETonMACE Cognitive Assessment Results Corporate Webcast Slides

Posted by: BearDownAZ on Dec 06, 2019 07:41PM
URL: https://www.resverlogix.com/upload/media...tonmace-cognitive-assessment-results.pdf